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A patient presents with a new bronchogenic carcinoma 5 years after laryngectomy for recurrent
laryngeal tumor and 13 years after chemoradiation for concurrent lung cancer with synchronous base-of-
tongue tumor. Due to his complex history and perceived limited respiratory reserve, he was felt high risk
for the completion pneumonectomy needed for resection of this new tumor. The attending surgeon
requested a full cardiopulmonary exercise test for risk assessment prior to surgery. We found that there
was no commercially available connector that would allow our CPET equipment to reliably collect res-
piratory gases from a patient with tracheostomy stoma or tube. We report here a simple coupling devised
“in house” that allowed for the performance of an interpretable test leading to a signiﬁcant change in
medical care.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cardiopulmonary exercise testing (CPET) uses a patient gener-
ated workload to provide objective assessment of the integrated
ﬁtness of the cardiac, respiratory, and musculoskeletal systems [1].
In use for decades in the evaluation of enigmatic dyspnea, CPET has
received increasing attention as a tool to determine readiness for
major cardiovascular and cancer surgeries [2,3]. In addition, there is
evidence that achieving certain milestones on CPET testing may
help risk stratify patients undergoing evaluation for major thoracic
resections [4,5]. A well-performed CPET that provides quality data
for analysis requires a cooperative and motivated subject, well-
trained technicians and supports staff, and properly calibrated
equipment that allows for simultaneous measurement of a host of
physiology parameters including collection of all inspired and
expired air without leak [6].
Cigarette smoking is associated with an increased incidence of a
host of chronic illnesses including coronary artery disease, chronic
obstructive lung disease (COPD) and a variety of malignancies.
Among the more common, and deadly, of these cancers includeCritical Care Medicine, Room
2, USA.
ss).
Ltd. This is an open access article uneoplasms of the Head and Neck and Bronchogenic Cancer. United
by the common exposure to chronic cigarette smoke, patients with
Head and Neck cancers and Lung cancers often have coexistent
COPD complicating their operative risk for curative resections. In
addition, a history of heavy cigarette smoking increases the risk for
second tumors even if the primary lesion is successfully treated.2. Case description
Mr. T is a 67-year-old smoker (150 pack-years) who presented in
2002 with dysphagia. He was found to have a locally advanced base
of tongue cancer (T4N0) and a right upper lobe lung nodule (T2N0),
both biopsy-proven to be squamous cell carcinomas. As it was
deemed impossible to distinguish a synchronous lung primary
tumor from metastasis, he was treated with primary radiotherapy
to both locations followed by a full course of cis-platinum doublet
adjuvant chemotherapy with a complete response at both sites. He
was disease free for 5 years and then lost to follow-up. He
continued to smoke and presented in 2010 with hemoptysis. Pan
endoscopy revealed a multifocal squamous cell neoplasm in the
larynx. He was referred to our institution and underwent total
laryngectomy without further adjuvant therapy; there was no
apparent new disease in the chest. At this point, he quit smoking. A
one-year surveillance positron emission tomography scan (PET) innder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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fall of 2014, he noted increasing chest congestion and sputum
production. There was no evidence for tracheoesophageal ﬁstula,
but chest imaging demonstrated a new right lung mass (Fig. 1A).
PET scan revealed an FDG-avid lesion involving both the posterior
segment of the right upper lobe and crossing the major ﬁssure into
the right lower lobe (Fig. 1B); there was no obvious nodal
involvement or disease outside the chest. The mass appeared
intimately associated with the bronchus intermedius. Bronchos-
copy revealed endobronchial tumor in a subsegment of the poste-
rior segment right upper lobe and bulging of the membranous
portion of the bronchus intermedius. Endobronchial ultrasound
conﬁrmed a large homogeneous soft tissue mass posterior to the
airway without an obvious tissue plane between the airway and
tumor. Biopsy revealed poorly differentiated squamous cell cancer.
Mr. T. had a long history of chronic bronchitis without frequent
exacerbations. He used nebulized combination short acting beta-
agonist and anticholinergic bronchodilators two to four times
daily. He had a daily cough productive of small amounts of thick
white sputum with recent occasional blood streaking. He had not
needed supplemental oxygen with any of his prior procedures. His
CT scan showed upper lobe predominant centrilobular emphysema
and he carried the diagnosis of COPD. Baseline PFT prior to his
previous cancer treatments could not be located in an outside
system. He noted dyspnea with walking a block on level ground orFig. 1. A) CT imaging showing mass in the posterior RUL. B) PET-CT showing FDG-avid
mass posterior to bronchus intermedius.with any incline; he was able to climb two ﬂights of stairs slowly in
Thoracic Surgery Clinic without ﬁnger oximetry desaturation,
though he did appear short of breath. He had no known heart
disease, no chronic edema, and no orthopnea.
3. Physiologic testing
Pulmonary function testingwas performed using a standard soft
rubber adapter than is held against the stoma to achieve a short-
term seal for spirometry and diffusion capacity (DLCO) testing.
Spirometry revealed a post-bronchodilator FEV1 of 2.18 L (63%
predicted), FVC of 3.24 (69%), and FEV1/FVC of 0.67. DLCO was
reduced at 44% predicted. MVV was reduced at 77 L/min
(>35  FEV1). Flow volume loops were reproducible without evi-
dence for leak on the VolumeeTime plot. Quantitative Ventilation/
Perfusion scanning (V/Q) revealed 16% perfusion right lung vs. 84%
left lung. Resting room air ABG showed pO2 ¼ 87, pCO2 ¼ 34, and
pH ¼ 7.45.
Based on prior experience, we have found that the standard
cycle-based CPET set-up in our lab is not compatible with the stoma
interface adapter we use for PFT testing; the leak is large and var-
iable. We contacted the manufacturer of our CPET equipment and
were told there was not a readily available connecting device
compatible with a stoma. We assumed we could place a tracheos-
tomy tube with inﬂatable cuff, but similarly, there are no standard
parts available to connect the 15 mm outside diameter (OD) tra-
cheostomy tube ﬁtting to the 30 mm OD CPET mass ﬂow sensor.
Any connector used would need to provide an airtight seal while
ﬂexible enough to allow for the movement inherent in a maximal
effort exercise test. Using parts available within the Respiratory
Therapy Department, we crafted a connector from the tracheos-
tomy tube to the mass ﬂow using a straight 15 mme15 mm tube
connector and a silicone rubber connector from Servo 900C
ventilator parts (part #MCCO.6343420) (Fig. 2 A & B). After dis-
cussing options with the patient, a #8 cuffed plastic Shiley tra-
cheostomy tube was placed using 2% lidocaine lubricating jelly.
After allowing 15 min to acclimate, the balloon was inﬂated to the
point of eliminating leak with Valsalva during tube occlusion
(8e10 cc air). Repeat spirometry revealed nearly identical expired
volumes (FEV1¼ 2.21, FVC¼ 3.42) and ﬂow volume loop. Using this
set up, the patient was able to breath comfortably through the
circuit with reproducible breath-to-breath volumes and no evi-
dence of leak.
The patient exercised on a cycle ergometer at a 30-Watt ramp
for 4 min and 20 s stopping due to leg fatigue (Fig 3). The test was
deemed near maximal as evidenced by achieving 83% of predicted
target heart rate (134 bpm), a Respiratory Quotient (RQ) at peak
exercise of 1.14, and signs of physical exhaustion. ABG revealed no
hypoxemia or hypercarbia at peak exercise, and a drop in serum
HCO3 of 3 mmol/L. There was no evidence for a ventilatory limi-
tation to this level of exercise with a breathing reserve of 35% (VE
max of 50 L/minwith MVV of 76), a peak respiratory rate of only 34,
and normal tidal volume recruitment (Vt/FVC going from 12% to
55%). Ventilation-perfusion parameters showed an elevated Aea
DO2 of 27 at rest that did not fall with exercise (Aea DO2 of 32 at
peak stress), but no desaturation noted. There was a normal drop in
the arterial to end tidal PCO2 gap and normal fall in VD/VT (41% at
rest to 18% at peak VO2), demonstrating the tube and connectors
did not seem to introduce a meaningful dead space load. There was
no apparent cardiac limitation with Anaerobic Threshold (AT)
occurring normally at 54% of predicted VO2 max (13 ml/kg), a
normal rise in the O2-pulse (a surrogate for stroke volume
recruitment), and no ECG changes to suggest ischemia. At peak
exercise, the patient's VO2 max was 1375 ml/min (65% of predicted)
or 15.7 ml/min/kg with patient 4 kg above ideal body weight
Fig. 2. Solving the connection conundrum. A) Mass ﬂow sensor, ﬂexible foam venti-
lator connector, and 15-15 mm tube connector; B) assembled connection.
Fig. 3. Patient performing cycle ergometer CPET with connector.
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work capacity without clear respiratory or cardiac limitation at a
level of work that may have been a submaximal effort. This sug-
gested his true maximal performance may have been a bit higher
and these ﬁndings likely included a component of lower extremity
aerobic deconditioning. Given that he exceeding a VO2 max of
15ml/kg, hewas enrolled in a 4 week long, three sessions per week,
outpatient Pulmonary Rehabilitation program with both objective
and subjective improvements in physical endurance. Formal CPET
was not repeated and he was offered completion pneumonectomy.
The patient underwent surgery that involved a protracted
dissection due to prior deﬁnitive external beam radiotherapy. The
patient was extubated in the recovery room and rapidly weaned to
humidiﬁed air. Final pathology revealed a T4 (invasion into medi-
astinum) N1, Stage 3B tumor with negative margins. From a res-
piratory standpoint his operation was a success. Unfortunately, in
the post-operative period he suffered a largemiddle cerebral artery
stroke and had an extended hospital stay. He was eventually dis-
charged to a long-term rehabilitation facility on humidiﬁed room
air with plans for adjunctive chemotherapy pending functional
recovery status.
4. Discussion
Risk stratiﬁcation for patients being considered for lung resec-
tion surgery remains an inexact science. Consensus guidelines
suggest acceptable surgical risk in patients with pre-resection
values for FEV1 and DLCO that both exceed 80% predicted
without further testing [4,5]. In those with lesser values, various
methods to predict post-resection physiology have been proposed.
These range from simple calculations of estimated contribution of
the planned resected segments to total lung function to the use of
quantitative V/Q scanning to estimate post-resection functional
lung [5,7]. Consensus guidelines suggest that if the calculated post-
operative predicted value for FEV1 and DLCO both exceed 40%,
pneumonectomy can be offered with reasonable expectation of
good post-surgical functional status. Some groups advocate drop-
ping that to 30% if much of the tissue targeted for resection is
emphysematous [5]. For predicted values less than 30% predicted,
most guidelines suggest further physiologic testing such as full
cardiopulmonary exercise testing [4].
The use of CPET for pre-operative risk assessment is also an
evolving science with many suggestions that the measured pa-
rameters may be more useful as continuous variable to track
response to therapy or deterioration in function rather than as
single threshold or “cutoff” indicators. However, there appears to
be some utility in predicted post-operative functional status and
complications in patients undergoing large vascular surgical re-
pairs, complex advanced cardiac support interventions, or large
lung resections [2,5,8]. Even major health care payors support the
use of CPET for lung resection preoperative assessment [9]. The
oxygen consumption at peak workload (VO2 max) is the most
commonly used parameter. Most guidelines suggest a value that
exceeds 15 ml/kg/min supports proceeding with surgery, while
values less than 10 ml/kg/min should be considered particularly
high risk. The 10e15 ml/kg/min range appears to be something of a
“gray” zone and suggests high risk. Some authors propose the use
of the VO2 at the Anaerobic Threshold (AT) as many patients with
underlying cardiopulmonary disease have trouble reaching typical
criteria for a maximal exercise effort. Suggested prohibitive values
fall in the range of 11e12 ml/kg/min at AT [4,5]. Unfortunately, data
from large cohort, randomized, controlled trials are lacking and are
challenging to design and implement.
Few of the patients included in the series making up the basis
for guidelines had prior resections or radiation lung injury, limiting
S. Overstreet et al. / Respiratory Medicine Case Reports 16 (2015) 11e1414the extrapolation of these tools to patients like ours. Furthermore,
the presence of a tracheostomy rendersmeasure of PFT difﬁcult and
subject to error. Therefore, although the V/Q scan predicted a post-
resection DLCO in the 35% range, it was felt his physiologic
complexity warranted more sophisticated testing. The use of a
manually held, occlusive soft rubber adapter is fairly common and
yields acceptable ﬂow volume loops and minimizes leak allowing
for DLCO measurement as well [10]. Others have devised
indwelling adapters that produce good results on spirometry [11].
Certainly, physiologic variables measured in this way can be used as
“worse case scenarios” is estimating what function might be with
normal upper airway anatomy. While one abstract described using
a manual occlusion adapter to obtain reliable CPET data [12], our
experience has been that the physical rigor of the test makes a
continuous seal difﬁcult and leads to lost data, often right at the
peak of exercise where it is most valuable. It does not appear there
is a commercially available tool for connecting an endotracheal or
tracheostomy tube to standardized exercise equipment that allows
for movement. The small sales market make manufacturing such a
device unattractive from a business model. We found one report
where a customized ﬂexible adapter was constructed on demand
for CPET testing with good success [13]. We describe here the re-
sults of creatively using parts on hand, at no cost to the patient,
which provided the hermetic, ﬂexible seal we needed to facilitate a
cycle ergometry to maximal patient effort. While we have a large
number of these parts on hand and demand is small, this is not a
sustainable solution going forward. The part is still commercially
available in limited supply and at rather high relative cost (personal
communication; Maquet Medical Systems). We would be inter-
ested in how other readers have solved this unusual pulmonary
physiologic conundrum.
5. Conclusion
In summary, we describe the successful performance of a full
cardiopulmonary exercise test on a laryngectomy patient using a
spare tube coupler and silicone rubber ventilator connector. This
system provided satisfactory seal and ﬂexibility and low airway
resistance and dead space to facilitate CEPT testing that correctly
predicted acceptable risk for a completion pneumonectomy.Acknowledgments
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